In vivo adenovirus-mediated p53 tumor suppressor gene therapy for colorectal cancer

Francis R. Spitz, Dao Nguyen, John M. Skibber, James Cusack, Jack A. Roth, Richard J. Cristiano

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Background: The p53 tumor suppressor gene is altered in up to 70% of colorectal cancers. Materials and Methods: We infected the colorectal cancer cell lines SW620 and KM12L4, in which p53 is mutated, with the replication-defective adenovirus Ad5/CMV/p53 to evaluate the effects of adenovirus-mediated wild-type p53 gene transfer Gene transduction was measured by cytochemical staining of cells infected with the Ad5/CMV/β-gal virus and expression of the wildtype p53 protein in these cells was demonstrated by immunoblotting. Results: Significant suppression of in vitro cell proliferation and induction of apoptosis (as measured by TUNEL assay labeling) were observed following Ad5/CMV/p53 infection. More importantly, similar effects were observed in vivo in an established nude mouse subcutaneous tumor model; significant suppression of tumor growth (60% 70%) and induction of apoptosis were observed following intratumoral injections of Ad5/CMV/p53. Conclusion: This form of therapy may provide a novel approach to colorectal cancer.

Original languageEnglish
Pages (from-to)3415-3422
Number of pages8
JournalAnticancer Research
Volume16
Issue number6 B
StatePublished - Dec 1 1996
Externally publishedYes

Fingerprint

Tumor Suppressor Genes
Adenoviridae
Genetic Therapy
Colorectal Neoplasms
Apoptosis
p53 Genes
In Situ Nick-End Labeling
Immunoblotting
Nude Mice
Neoplasms
Cell Proliferation
Staining and Labeling
Viruses
Cell Line
Injections
Growth
Infection
Genes
Proteins
Therapeutics

Keywords

  • Adenovirus
  • Colon cancer
  • Gene therapy
  • p53

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Spitz, F. R., Nguyen, D., Skibber, J. M., Cusack, J., Roth, J. A., & Cristiano, R. J. (1996). In vivo adenovirus-mediated p53 tumor suppressor gene therapy for colorectal cancer. Anticancer Research, 16(6 B), 3415-3422.

In vivo adenovirus-mediated p53 tumor suppressor gene therapy for colorectal cancer. / Spitz, Francis R.; Nguyen, Dao; Skibber, John M.; Cusack, James; Roth, Jack A.; Cristiano, Richard J.

In: Anticancer Research, Vol. 16, No. 6 B, 01.12.1996, p. 3415-3422.

Research output: Contribution to journalArticle

Spitz, FR, Nguyen, D, Skibber, JM, Cusack, J, Roth, JA & Cristiano, RJ 1996, 'In vivo adenovirus-mediated p53 tumor suppressor gene therapy for colorectal cancer', Anticancer Research, vol. 16, no. 6 B, pp. 3415-3422.
Spitz FR, Nguyen D, Skibber JM, Cusack J, Roth JA, Cristiano RJ. In vivo adenovirus-mediated p53 tumor suppressor gene therapy for colorectal cancer. Anticancer Research. 1996 Dec 1;16(6 B):3415-3422.
Spitz, Francis R. ; Nguyen, Dao ; Skibber, John M. ; Cusack, James ; Roth, Jack A. ; Cristiano, Richard J. / In vivo adenovirus-mediated p53 tumor suppressor gene therapy for colorectal cancer. In: Anticancer Research. 1996 ; Vol. 16, No. 6 B. pp. 3415-3422.
@article{19859937c7f44660a30a20b2b0e03387,
title = "In vivo adenovirus-mediated p53 tumor suppressor gene therapy for colorectal cancer",
abstract = "Background: The p53 tumor suppressor gene is altered in up to 70{\%} of colorectal cancers. Materials and Methods: We infected the colorectal cancer cell lines SW620 and KM12L4, in which p53 is mutated, with the replication-defective adenovirus Ad5/CMV/p53 to evaluate the effects of adenovirus-mediated wild-type p53 gene transfer Gene transduction was measured by cytochemical staining of cells infected with the Ad5/CMV/β-gal virus and expression of the wildtype p53 protein in these cells was demonstrated by immunoblotting. Results: Significant suppression of in vitro cell proliferation and induction of apoptosis (as measured by TUNEL assay labeling) were observed following Ad5/CMV/p53 infection. More importantly, similar effects were observed in vivo in an established nude mouse subcutaneous tumor model; significant suppression of tumor growth (60{\%} 70{\%}) and induction of apoptosis were observed following intratumoral injections of Ad5/CMV/p53. Conclusion: This form of therapy may provide a novel approach to colorectal cancer.",
keywords = "Adenovirus, Colon cancer, Gene therapy, p53",
author = "Spitz, {Francis R.} and Dao Nguyen and Skibber, {John M.} and James Cusack and Roth, {Jack A.} and Cristiano, {Richard J.}",
year = "1996",
month = "12",
day = "1",
language = "English",
volume = "16",
pages = "3415--3422",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "6 B",

}

TY - JOUR

T1 - In vivo adenovirus-mediated p53 tumor suppressor gene therapy for colorectal cancer

AU - Spitz, Francis R.

AU - Nguyen, Dao

AU - Skibber, John M.

AU - Cusack, James

AU - Roth, Jack A.

AU - Cristiano, Richard J.

PY - 1996/12/1

Y1 - 1996/12/1

N2 - Background: The p53 tumor suppressor gene is altered in up to 70% of colorectal cancers. Materials and Methods: We infected the colorectal cancer cell lines SW620 and KM12L4, in which p53 is mutated, with the replication-defective adenovirus Ad5/CMV/p53 to evaluate the effects of adenovirus-mediated wild-type p53 gene transfer Gene transduction was measured by cytochemical staining of cells infected with the Ad5/CMV/β-gal virus and expression of the wildtype p53 protein in these cells was demonstrated by immunoblotting. Results: Significant suppression of in vitro cell proliferation and induction of apoptosis (as measured by TUNEL assay labeling) were observed following Ad5/CMV/p53 infection. More importantly, similar effects were observed in vivo in an established nude mouse subcutaneous tumor model; significant suppression of tumor growth (60% 70%) and induction of apoptosis were observed following intratumoral injections of Ad5/CMV/p53. Conclusion: This form of therapy may provide a novel approach to colorectal cancer.

AB - Background: The p53 tumor suppressor gene is altered in up to 70% of colorectal cancers. Materials and Methods: We infected the colorectal cancer cell lines SW620 and KM12L4, in which p53 is mutated, with the replication-defective adenovirus Ad5/CMV/p53 to evaluate the effects of adenovirus-mediated wild-type p53 gene transfer Gene transduction was measured by cytochemical staining of cells infected with the Ad5/CMV/β-gal virus and expression of the wildtype p53 protein in these cells was demonstrated by immunoblotting. Results: Significant suppression of in vitro cell proliferation and induction of apoptosis (as measured by TUNEL assay labeling) were observed following Ad5/CMV/p53 infection. More importantly, similar effects were observed in vivo in an established nude mouse subcutaneous tumor model; significant suppression of tumor growth (60% 70%) and induction of apoptosis were observed following intratumoral injections of Ad5/CMV/p53. Conclusion: This form of therapy may provide a novel approach to colorectal cancer.

KW - Adenovirus

KW - Colon cancer

KW - Gene therapy

KW - p53

UR - http://www.scopus.com/inward/record.url?scp=0030514283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030514283&partnerID=8YFLogxK

M3 - Article

C2 - 9042200

AN - SCOPUS:0030514283

VL - 16

SP - 3415

EP - 3422

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 6 B

ER -